Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Both hold potential in different domains: Bitcoin as peer-to-peer money and blockchain as a platform for diverse, programmable applications.
28,588 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Imagine a loan that travels with you—from city to city and house to house. Portable mortgages promise mobility, but t...
A sharp move in Nebius Group after announcing a massive capital raise highlights how debt and potential dilution can ...
JPMorgan CEO Jamie Dimon dismissed Donald Trump’s $5 billion debanking lawsuit as meritless, but said he understands ...
Applied Materials and Micron defy a broader market lull, driven by persistent AI memory demand and a healthy equipmen...
Emerging markets are outpacing the S&P 500 in 2026, with EEM posting a double-digit lead year-to-date. The rally cent...
A cruise stock jumps as an activist investor takes a stake, signaling potential governance shifts. This article break...
Investors are buzzing about a potential silver surge. This guide breaks down the chances of american silver going $70...
Chasing overnight riches rarely pays off. This guide shows how to identify the fastest stock that could steadily grow...
A shadowy hosting network in Russia reportedly kept cybercrime online, driving millions in losses. This guide explain...
Want crypto exposure without sacrificing diversification? This guide shows how crypto etfs part diversified fits into...
Could XRP slip below $2 by 2027? This guide breaks down the three big hurdles, explains why a lower price is plausibl...